Novartis AG (NVSEF) Financials

NVSEF Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 119.2 billion 80.0 billion
Dec. 31, 2025 115.5 billion 69.0 billion
Sept. 30, 2025 107.3 billion 62.5 billion
June 30, 2025 104.4 billion 62.3 billion

NVSEF Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 3.3 billion 303.0 million
Dec. 31, 2025 1.5 billion 299.0 million
Sept. 30, 2025 5.7 billion 268.0 million
June 30, 2025 6.1 billion 267.0 million

NVSEF Net Income
Graph available only for paid members. Upgrade to see it.
DateNet Income
March 31, 2026 3.1 billion
Dec. 31, 2025 2.4 billion
Sept. 30, 2025 3.9 billion
June 30, 2025 4.0 billion

NVSEF Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 7.0 billion 37.7 billion 1.7 billion
Dec. 31, 2025 11.6 billion 29.6 billion 1.9 billion
Sept. 30, 2025 9.8 billion 22.6 billion 1.9 billion
June 30, 2025 7.0 billion 22.5 billion 1.9 billion

NVSEF Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 1.9 billion
Dec. 31, 2025 1.9 billion
Sept. 30, 2025 2.0 billion
June 30, 2025 2.0 billion

NVSEF Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 339.3 million 2.7 billion 3.1 billion -
Dec. 31, 2025 625.6 million 2.9 billion 3.5 billion -
Sept. 30, 2025 831.0 million 2.9 billion 3.3 billion -
June 30, 2025 558.0 million 2.7 billion 3.4 billion -

NVSEF Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 12.9 billion 3.4 billion
Dec. 31, 2025 13.4 billion 3.6 billion
Sept. 30, 2025 14.4 billion 3.5 billion
June 30, 2025 14.8 billion 3.3 billion

NVSEF

Price: $144.88

52 week price:
110.74
171.29

Dividend Yield: 3.29%

5-year range yield:
3.29%
8.96%

Forward Dividend Yield: 6.61%

Payout Ratio: 76.50%

Payout Ratio Range:
0.24%
389.86%

Dividend Per Share: 9.51 USD

Earnings Per Share: 6.85 USD

P/E Ratio: 21.02

Exchange: PNK

Sector: Healthcare

Industry: Drug Manufacturers - General

Market Capitalization: 275.0 billion

Average Dividend Frequency: 2

Years Paying Dividends: 30

DGR3: 5.96%

DGR5: 5.16%

DGR10: 3.98%

DGR20: 7.45%

Links: